The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUAI.L Regulatory News (UAI)

  • There is currently no data for UAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Share in Harwell Campus

2 Apr 2020 07:00

RNS Number : 5004I
U and I Group PLC
02 April 2020
 

2 April 2020

 

U and I Group PLC

 

 

U+I disposes of its share in the Harwell Campus, delivering development and trading gains of approximately £11 million

 

U+I (LSE:UAI), the specialist regeneration developer and investor, today announces that it has exchanged on the sale of its holding in Harwell Campus, the world leading science and technology campus in Oxfordshire, to Brookfield Capital Partners ("Brookfield"), on behalf of Brookfield Strategic Real Estate Partners III ("BSREP III"), for an initial cash payment of £28 million, plus deferred payments of £13.74 million. This delivers development and trading gains to U+I of approximately £11 million, subject to formal audit. The Company expects these gains to be in FY2020, subject to discussions with its auditors. U+I has also sold its 100% owned, adjoining Gemini Building to Brookfield for £7.5 million, marginally above book value, giving an aggregate net cash receipt of c.£44 million.

 

The disposal of U+I's share of the joint venture in Harwell follows an extensive marketing and due diligence process which saw strong interest from a number of international investors, attracted by the potential of this internationally renowned 700-acre science campus, grounded in over £2 billion of world-leading scientific infrastructure. The additional sale of the Gemini Building, held in our investment portfolio, was opportunistic and reflected a fair value for this asset, whilst providing additional cash to our business.

 

U+I will provide an unaudited post close trading update on 15 April.

 

Matthew Weiner, CEO of U+I said:

"Brookfield has a trusted reputation for nurturing and growing assets in the real estate sector. We felt they were the right choice to drive the next stage of growth at this internationally renowned innovation and science campus in the Oxford corridor, giving Harwell the capital commitment it needs to unlock its potential for the future as a hub for pioneering research. With such strong demand for science and research led facilities, it was the right time for U+I to sell its share in the joint venture, which also provides a significant cash injection that further strengthens U+I's balance sheet."

 

 

ENDS

 

 

For further information, please contact: 

 

U+I

Nicola Krafft

+44 (0) 20 7828 4777

ir@uandiplc.com

 

Camarco (Financial PR Adviser)

Geoffrey Pelham-Lane / Tom Huddart

+44 (0)20 3757 4985 / 4991

uandi@camarco.co.uk 

 

About U+I

U+I is a specialist regeneration developer and investor.

 

With a >£11.5 billion portfolio of complex, mixed-use, community-focused regeneration projects including a £147.1 million investment portfolio, we are unlocking urban sites bristling with potential in the London City Region (within one hour's commute from Central London), Manchester and Dublin. We exist to create long-term socio-economic benefit for the communities in which we work, delivering sustainable returns to our shareholders.

 

To find out more, visit www.uandiplc.com or follow us @uandiplc  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISUPUPUCUPUPUG
Date   Source Headline
2nd Nov 20213:25 pmRNSForm 8.3 - U AND I GROUP PLC
2nd Nov 20213:20 pmRNSForm 8.3 - U and I Group plc
2nd Nov 20212:30 pmRNSForm 8.3 - U and I Group plc
2nd Nov 20212:19 pmRNSForm 8.3 - U and I Group plc
2nd Nov 20211:55 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - U AND I GROUP PLC - Ordinary Shares
2nd Nov 20211:04 pmPRNForm 8.3 - U and I Group Plc
2nd Nov 202112:00 pmRNSForm 8.5 (EPT/RI) - U and I Group Plc
2nd Nov 202111:23 amPRNForm 8.3 - U & I Group plc
2nd Nov 202111:21 amRNSForm 8.5 (EPT/RI) - U and I Group plc
2nd Nov 202110:40 amRNSForm 8.3 - U AND I Group Plc
2nd Nov 20219:52 amRNSForm 8.5 (EPT/RI)
2nd Nov 20219:45 amRNSForm 8.3 - U and I Group Plc
1st Nov 202111:53 amRNSRule 2.9 Announcement
1st Nov 20217:00 amRNSRecommended cash offer for U and I Group PLC
1st Oct 202112:02 pmRNSDirector/PDMR Shareholding
9th Sep 20213:56 pmRNSResult of AGM
8th Sep 20217:00 amRNSMorden Wharf planning decision
26th Jul 20218:00 amRNSDirector/PDMR Shareholding
20th Jul 202111:15 amRNSHolding(s) in Company
8th Jul 20217:30 amRNSHolding(s) in Company
1st Jul 202111:44 amRNSDirector/PDMR Shareholding
30th Jun 20212:57 pmRNSDirector/PDMR Shareholding
29th Jun 20214:49 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:20 pmRNS8 Albert Embankment planning decision
18th Jun 20217:01 amRNSAnnual Financial Report and Notice of AGM
9th Jun 20213:27 pmRNSDirector/PDMR Shareholding
2nd Jun 20217:00 amRNSDirector/PDMR Shareholding
26th May 20217:07 amRNSResults for the year ended 31 March 2021
26th May 20217:00 amRNSBoard Changes
11th May 20217:00 amRNSAppointment of CFO
14th Apr 20214:35 pmRNSPrice Monitoring Extension
31st Mar 20214:51 pmRNSDirector/PDMR Shareholding
31st Mar 20214:20 pmRNSDirector/PDMR Shareholding
10th Feb 20215:06 pmRNSDirector/PDMR Shareholding
27th Jan 20217:30 amRNSDirector/PDMR Shareholding
26th Jan 202110:45 amRNSDirector/PDMR Shareholding
25th Jan 20212:54 pmRNSHolding(s) in Company
25th Jan 20212:38 pmRNSDirector/PDMR Shareholding
21st Jan 20214:29 pmRNSDirector/PDMR Shareholding
19th Jan 20217:01 amRNSInterim Results
19th Jan 20217:00 amRNSDirectorate Changes
5th Jan 202111:06 amRNSDirector/PDMR Shareholding
4th Jan 202110:23 amRNSBlock listing Interim Review
27th Nov 20204:40 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSNotice of Interim Results
30th Sep 20203:02 pmRNSDirector/PDMR Shareholding
24th Sep 20207:00 amRNSPositive planning decision in Tunbridge Wells
18th Sep 20207:00 amRNSNew joint venture partnership
10th Sep 20201:43 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.